Search by Drug Name or NDC
NDC 62135-0525-90 Terbutaline Sulfate 5 mg/1 Details
Terbutaline Sulfate 5 mg/1
Terbutaline Sulfate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC.. The primary component is TERBUTALINE SULFATE.
MedlinePlus Drug Summary
Terbutaline is used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, and emphysema. Terbutaline is in a class of medications called beta agonists. It works by relaxing and opening the airways, making it easier to breathe.
Related Packages: 62135-0525-90Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Terbutaline
Product Information
| NDC | 62135-0525 |
|---|---|
| Product ID | 62135-525_f5ef3687-6d9c-1d2c-e053-2a95a90a4eca |
| Associated GPIs | |
| GCN Sequence Number | 005026 |
| GCN Sequence Number Description | terbutaline sulfate TABLET 5 MG ORAL |
| HIC3 | J5D |
| HIC3 Description | BETA-ADRENERGIC AGENTS |
| GCN | 20071 |
| HICL Sequence Number | 002071 |
| HICL Sequence Number Description | TERBUTALINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Terbutaline Sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Terbutaline Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | TERBUTALINE SULFATE |
| Labeler Name | Chartwell RX, LLC. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077152 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0525-90 (62135052590)
| NDC Package Code | 62135-525-90 |
|---|---|
| Billing NDC | 62135052590 |
| Package | 90 TABLET in 1 BOTTLE (62135-525-90) |
| Marketing Start Date | 2023-02-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |